Prospective Population Based Cohort Study on Cognitive and Cardiovascular Aging (MonaLisaPredor)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

520 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-05-22

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aging is a long term process, starting early in life, and progressively affecting various functions and organs. Cardiovascular diseases and cognitive impairment are two conditions related to advancing age and sharing common risk factors. The Mona Lisa- PREDOR study is a population-based prospective cohort study carried out to develop risk prediction algorithms aimed at identifying people who are the most likely to develop impaired psychometric and cognitive functioning and impaired cardiovascular risk, in the coming years.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes

NCT04583800

Diabetes Mellitus, Type 2 Heart Failure Cognitive Decline

RECRUITING

Connection Between General Practitioner's (GP's) Estimation of Cardiovascular Risk and Theoretical Calculation in France

NCT01039402

Cardiovascular Risk

COMPLETED

Identification and Validation of a Prediction Model for CARDIOvascular Events

NCT06952062

Cardiovascular Diseases

ACTIVE_NOT_RECRUITING

Identification of New Biomarkers for the Prediction of Cardiovascular Events

NCT04809506

Cardiovascular Diseases

RECRUITING

Socioeconomic Deprivation and Peripheral Arterial Disease

NCT03693053

Peripheral Arterial Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is aimed at identifying predictors of impaired changes in psychometric and cognitive performances and level of cardiovascular risk, over a seven-year period, and to develop risk prediction algorithms. Main secondary objectives are to study response to psychometric and cognitive tests according to age, and to estimate the prevalence of the frailty syndrome according to age.

The design is a prospective cohort study carried out among 1500 men and women from the general population, aged 42-89 years, and living in South-western France. Except for participants aged 80-89 years, all participants have been previously assessed in 2005-2007, as regard to their psychometric and cognitive performances and level of cardiovascular risk, as part of the Mona Lisa study.

Data collection includes a detailed questionnaire on previous medical history, drug intake, education level, and life habits; a standardised clinical examination; psychometric tests (word list learning test, digit symbol substitution test, word fluency test and Stroop test), and a fasting blood sample. Level of cardiovascular risk and frailty syndrome were assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women aged 42-79 years, living in South-western France, who participated in the Mona Lisa Study (2005-2007) (in the Mona Lisa study, participants were selected by drawing on polling lists)
* Men and women aged 80-89 years, living in South-western France, selected by drawing on polling lists.

Exclusion Criteria

* Subject who refuses to participate (who refuses to sign the inform consent)
* Subject not affiliated to a health assurance system
* Subject with altered cognitive functioning compromising the understanding of the information on the study, and not accompanied by a trusted third party.

Minimum Eligible Age

42 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes